Show items per page
Elements: 3
Page 1 on 1
 TitleAuthors / EditorsDate
add to browser selection
Clinical validity of cerebrospinal fluid Aβ42, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework Mattsson, Niklas; Lönneborg, Anders; Boccardi, Marina; Blennow, Kaj; Hansson, Oskar 2017
add to browser selection
Preclinical effects of APOE ε4 on cerebrospinal fluid Aβ42 concentrations Lautner, Ronald; Insel, Philip S; Skillbäck, Tobias; Olsson, Bob; ... Zetterberg, Henrik 2017
add to browser selection
CSF biomarkers for the differential diagnosis of Alzheimer's disease: A large-scale international multicenter study Ewers, Michael; Mattsson, Niklas; Minthon, Lennart; Molinuevo, José L; ... Hampel, Harald 2015